COVID-19 cases are sharply increasing in parts of Asia, particularly Singapore and Hong Kong, driven by the fast-spreading ...

By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals will price its shares ...

Singapore saw a significant increase in COVID-19 infections. The number of cases jumped from around 11,100 in the last week ...

Health authorities in India are monitoring reports of rising Covid-19 cases in Singapore and Hong Kong, but fresh concerns ...

Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, as a resurgent ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...

Asian countries such as Singapore and Hong Kong have noted a surge in Covid-19 cases over the last few weeks. Health ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

As Covid-19 cases surge in parts of Asia, including Singapore and Hong Kong, Indian health authorities have ramped up ...

SINGAPORE] Chinese electric vehicle battery maker Contemporary Amperex Technology Company Limited (CATL) has drawn strong ...

Singapore’s transformation has been driven by a business-friendly regulatory environment and sustained investments in ...